Navigation Links
Hospira Names Ken Meyers to Lead Human Resources
Date:11/10/2008

LAKE FOREST, Ill., Nov. 10 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, announced today that Ken Meyers has been named senior vice president, Organizational Transformation and People Development. In this capacity, he will lead the global human resources function with a focus on advancing Hospira's high-performance culture and organizational excellence. Meyers succeeds Henry Weishaar, who is retiring Dec. 31, 2008, and will report directly to Christopher Begley, chairman and chief executive officer.

"Ken's extensive cross-industry experience in operations and human resources, combined with his track record of building team-based environments that align with the company's culture and vision, will be integral to Hospira as we nurture a climate that fosters innovation and supports significant global market expansion," said Begley. "Hospira's employees are our greatest resource and competitive advantage, and I am confident entrusting this important function to Ken."

Most recently, Meyers, 46, was a partner at Oliver Wyman, an international management consulting firm. A specialist in leadership development, Meyers has extensive experience working with senior teams in facilitating their acceleration to high performance, and has served as a principal consultant and coach to senior executives at well-known companies such as Amgen, L'Oreal, Nike, Novartis, Time Warner, Sara Lee and Unilever.

Prior to joining Oliver Wyman, Meyers was senior vice president, Human Resources, Starbucks Coffee International, leading human resources strategy and direction as Starbucks expanded internationally through company-owned, licensed and joint-venture operations. Throughout his more than 20-year career in global human resources and senior-line management, he also held various leadership positions with Disney, Gymboree and United Technologies.

Meyers earned his bachelor's degree in International Business and Human Resources Management from the Wharton School of the University of Pennsylvania, and his master's of business administration from the Harvard Business School.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hospira.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO)


'/>"/>
SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hospira Reports Third-Quarter 2008 Results
2. Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12
3. FDA Approves New Indication for Hospiras Precedex (Dexmedetomidine HCL) Injection
4. Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And Equipment
5. Hospira Reports Second-Quarter 2008 Results
6. Hospira Hosts Conference Call for Second-Quarter 2008 Earnings
7. Hospira Highlights Strategic Initiatives at Its 2008 Annual Meeting of Shareholders
8. Hospira to Present at the Bank of America 2008 Health Care Conference on May 14
9. Hospira Acquires Sculptor
10. Hospira Hosts Conference Call for First-Quarter 2008 Earnings
11. Hospira to Present at the Bear Stearns 10th Annual London Healthcare Conference on March 13
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... January 16, 2017 , ... Board-certified oculoplastic ... Journal , the official journal of The American Society for Aesthetic Plastic Surgery, ... The procedure is designed to correct drooping, retracted lower eyelids, which usually result ...
(Date:1/16/2017)... UT (PRWEB) , ... January 16, 2017 , ... One ... not only to treat, but to test for, as well. The money spent screening ... every year.(1) Doctors in the U.S. screen patients for cancer more than in any ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... Executive Officer of the medical device company, effective immediately. , “This is perfect ... “Kevin has a strong track record in medical device market development and revenue ...
(Date:1/15/2017)... ... , ... In this role, Courtney will be responsible for developing new business ... friendly mark. This certification program was created by ASL and the nonprofit Asthma and ... suitable for the 60+ million people living in the U.S. with asthma and allergies. ...
(Date:1/15/2017)... ... ... is announcing the release of an updated version of their top selling clipper, the ... wide jaws that will accommodate nails up to 4mm in thickness . Nails like ... reinforced for extra strength when pressing down on dense nails which can be a hindrance ...
Breaking Medicine News(10 mins):
(Date:1/14/2017)... , Jan. 14, 2017  Johnson & Weaver, LLP announces ... purchasers of Zimmer Biomet Holdings, Inc. (NYSE: ZBH ... October 31, 2016 (the "Class Period"). Zimmer Biomet ... markets orthopaedic reconstructive products, such as knee and hip reconstructive ... ...
(Date:1/13/2017)... , January 13, 2017 ... "Transfection Reagents and Equipment Market by Method (Biochemical ... Application (Biomedical, Protein Production), End User - Global ... studies the global market from 2016 to 2021. ... Billion by 2021 from USD 715.4 Million in ...
(Date:1/13/2017)... , January 13, 2017 The 2016 ... industry, with several states voting in favor of legalizing cannabis ... largest Cannabis market in the U.S. In addition, the state ... mark in annual cannabis products sales. The ArcView Group has ... which the legal cannabis sales in the U.S. last year ...
Breaking Medicine Technology: